Showing results (21-30 of 1,563) with videos related to
Sort By:
Pageof 157
British Journal of Haematology|December 1, 1989
No preferential use of the VH(V) family in human multiple myelomaG Clofent, F Brockly, T Commes, et al.British Journal of Haematology|March 1, 1989
No detectable malignant B cells in the peripheral blood of patients with multiple myelomaG Clofent, B Klein, T Commes, et al.European Journal of Immunology|November 1, 1992
High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivoZ Y Lu, J Brochier, J Wijdenes, et al.Immunology|March 1, 1992
Major immunoglobulin capping deficiency in the peripheral blood B cells of patients with Sjögren's syndromeR Bataille, X G Zhang, C Duperray, et al.Blood|October 15, 1995
Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatmentsZ Y Lu, H Brailly, J Wijdenes, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
IFN-alpha induces autocrine production of IL-6 in myeloma cell linesM Jourdan, X G Zhang, M Portier, et al.British Journal of Haematology|January 14, 1999
Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 productionV Costes, M Portier, Z Y Lu, et al.Cytokine|November 1, 1993
Overall interleukin-6 production exceeds 7 mg/day in multiple myeloma complicated by sepsisZ Y Lu, H Brailly, J F Rossi, et al.Journal of Clinical Immunology|January 1, 1989
The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factorsT Commes, B Klein, M Jourdan, et al.Arthritis and Rheumatism|March 1, 1990
Constitutive production of interleukin-6 and immunologic features in cardiac myxomasM Jourdan, R Bataille, J Seguin, et al.Pageof 157